• 1
    Brocklehurst P, Gates S, McKenzie-McHarg K, Alfirevic Z, Chamberlain G. Are we prescribing multiple courses of antenatal corticosteroids? A survey of practice in the UK. Br J Obstet Gynaecol 1999; 106: 977979.
  • 2
    Ogueh O, Khastgir G, Studd J, Jones J, Alaghband-Zadeh J, Johnson M. Antenatal corticosteroid therapy and risk of osteoporosis, Br J Obstet Gynaecol 1998; 105: 551555.
  • 3
    Spencer C, Smith P, Rafla N, Weatherell R. Corticosteroids in pregnancy and osteonecrosis of the femoral head. Obstet Gynecol. In press.
  • 4
    French N, Hagan R, Evans S, Godfrey M, Newnham J. Repeated antenatal corticosteroids: size at birth and subsequent development. Am J Obstet Gynecol 1999; 180: 114121.
  • 5
    Turrentine M, Dupras-Wilson P, Wilkins I. A retrospective analysis of the effect of antenatal steroid administration on the incidence of respiratory distress syndrome in preterm twin pregnancies. Am J Perinatol 1996; 13: 351354.
  • 6
    Ardila J, LeGuennec J, Papageorgiou A. Influence of antenatal betamethasone and gender cohabitation on outcome of twin pregnancies 24 to 34 weeks of gestation. Semin Perinatal 1994; 18: 1518.
  • 7
    Garite J, Rumney P, Briggs G. A randomized placebo-controlled trial of betamethasone for the prevention of respiratory distress syndrome at 24 to 28 weeks' gestation. Am J Obstet Gynecol 1992; 166: 646651.